The science behind the gut-brain connection
The relationship between gut health and mental wellbeing is attracting growing interest from consumers and supplement developers. It’s reported that around one in four people will experience mental health challenges at some point in their lives, while at present an estimated 280 million people worldwide are living with depression, and 30% report sleep issues.
But translating that interest into credible products requires more than a general probiotic proposition. It means understanding which strains have been studied, the specific cohort, and against which outcomes.
The gut-brain axis describes the two-way communication between the gut microbiome and the brain through immune, endocrine and neural pathways. A growing understanding of the role of the enteric nervous system in gut-brain communication is also broadening interest in probiotics for mood and mental wellbeing. More than 46% of global consumers believe a healthy digestive system can improve mood and emotional wellbeing while helping reduce stress.
Research is shedding welcome light on how gut health interacts with stress response, mood and cognitive function. Yet probiotic effects cannot be assumed to apply across all strains, and the evidence for each strain must be assessed on its own merit.
What the research shows for HEAL9
Probi’s proprietary probiotic strain, Lactiplantibacillus plantarum HEAL9 (HEAL9), has been investigated in human studies examining biological responses to stress and cognitive performance. The wider research also explores memory, attention, mood and sleep providing a broader picture of the outcomes being investigated through targeted gut-brain research.
In a randomised, double-blind, placebo-controlled study published in 2020, researchers investigated four weeks of HEAL9 supplementation in people experiencing chronic stress.1
Following an acute stress test, participants receiving HEAL9 had significantly lower plasma levels of two inflammatory markers, soluble fractalkine and CD163, compared to placebo. No significant between-group differences were found in cortisol levels of cardiovascular reactivity. These findings provide evidence of an effect on specific inflammatory responses associated with acute stress.
A second study published in 2023 explored cognitive performance in 129 healthy adults experiencing moderate stress. Participants received HEAL9 or a placebo for 12 weeks. Compared to placebo, HEAL9 was associated with significant improvements across four cognitive tests assessing processing, working memory, associative learning and word recall. The researchers also observed trends towards improvements in aspects of mood and sleep.
Together, these studies add to the evidence base for HEAL9 in the gut-brain area, with findings spanning stress-related biological responses and cognitive function.
From research to product development
For supplement brands, strain-specific evidence is central to building a credible product proposition. Evidence for one probiotic cannot simply be transferred to another, nor should changes in biological markers automatically be presented as benefits consumers will experience. As interest in probiotics for mental health grows, products marketed with psychological benefit claims underline the need for robust, strain-specific evidence. In fact, 74% of global consumers say science-based claims are important when choosing probiotic products.
Formulators and product developers should assess the evidence against the intended benefit, target population and proposed use. Study design, dosage, intervention duration and the outcome measures all matter when determining what the research supports. It is equally important to distinguish between outcomes measured directly in clinical studies and the consumer-facing benefits a brand ultimately wants to communicate. Finished product claims must also meet the regulatory requirements of the intended market.
As interest in mental wellbeing continues to inform supplement innovation, HEAL9 provides a research-backed starting point for exploring gut-brain health concepts. Its clinical evidence illustrates why selecting a probiotic strain should begin with the science, with product positioning and claims built around what evidence can substantiate.
Explore Probi’s research and product development approach by visiting the Probi website.
